ReviewCancers2022

Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite Instability.

Beatrice Borelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.